Protagenic Therapeutics (PTIX)

Currency in USD
0.593
-0.022(-3.58%)
Closed·
PTIX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.5100.650
52 wk Range
0.26014.280
Key Statistics
Prev. Close
0.615
Open
0.615
Day's Range
0.51-0.65
52 wk Range
0.26-14.28
Volume
6.63K
Average Volume (3m)
114.42K
1-Year Change
-90.7882%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PTIX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Protagenic Therapeutics News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Protagenic Therapeutics Company Profile

Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.

Compare PTIX to Peers and Sector

Metrics to compare
PTIX
Peers
Sector
Relationship
P/E Ratio
-−3.8x−0.6x
PEG Ratio
-0.100.00
Price/Book
-3.9x2.6x
Price / LTM Sales
-113.8x3.4x
Upside (Analyst Target)
-40.4%40.2%
Fair Value Upside
Unlock−7.0%4.8%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Nov 26, 2025
EPS / Forecast
-0.47 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

PTIX Income Statement

People Also Watch

6.830
TGL
-2.57%
1.0100
KITT
+13.48%
13.560
ONDS
-2.38%
0.880
KTTA
+0.57%
2.690
SOPA
+11.16%

FAQ

What Is the Protagenic Therapeutics (PTIX) Stock Price Today?

The Protagenic Therapeutics stock price today is 0.593

What Stock Exchange Does Protagenic Therapeutics Trade On?

Protagenic Therapeutics is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Protagenic Therapeutics?

The stock symbol for Protagenic Therapeutics is "PTIX."

What Is the Protagenic Therapeutics Market Cap?

As of today, Protagenic Therapeutics market cap is 349.26K.

What Is Protagenic Therapeutics's Earnings Per Share (TTM)?

The Protagenic Therapeutics EPS (TTM) is 0.00.

From a Technical Analysis Perspective, Is PTIX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Protagenic Therapeutics Stock Split?

Protagenic Therapeutics has split 5 times.

How Many Employees Does Protagenic Therapeutics Have?

Protagenic Therapeutics has 3 employees.

What is the current trading status of Protagenic Therapeutics (PTIX)?

As of Jan 14, 2026, Protagenic Therapeutics (PTIX) is trading at a price of 0.593, with a previous close of 0.615. The stock has fluctuated within a day range of 0.510 to 0.650, while its 52-week range spans from 0.260 to 14.280.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.